Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
MIND, Mediterranean Diets May Delay Parkinson Onset
01/14/2021
In a new study, researchers have found that nutritional approaches may be a key avenue in slowing the onset of Parkinson disease.
In a new study, researchers have found that nutritional approaches may be a key avenue in slowing the onset of Parkinson disease.
In a new study, researchers have...
01/14/2021
Neurology
News
Oligoclonal IgM Bands in Relapsing MS: A Potential Biomarker of Long-Term Disability?
01/13/2021
In a new study published in Multiple Sclerosis Journal, researchers investigated potential cerebrospinal fluid markers for long-term disability among patients with relapsing multiple sclerosis.
In a new study published in Multiple Sclerosis Journal, researchers investigated potential cerebrospinal fluid markers for long-term disability among patients with relapsing multiple sclerosis.
In a new study published in...
01/13/2021
Neurology
News
New Risk Score Found to Successfully Predict Neurological Deterioration of Ischemic Origin in Minor Stroke, LVO
01/12/2021
In a multicentric retrospective cohort study, researchers derived and externally validated a risk score to predict neurological deterioration of ischemic origin among patients with minor stroke and large vessel occlusion treated with...
In a multicentric retrospective cohort study, researchers derived and externally validated a risk score to predict neurological deterioration of ischemic origin among patients with minor stroke and large vessel occlusion treated with...
In a multicentric retrospective...
01/12/2021
Neurology

Advertisement

News
FDA Clears Wearable EEG Device System
01/06/2021
The new device, which was given 510(k) clearance from the US Food and Drug Administration, allows for the remote diagnosis, monitoring, and assessment of epilepsy.
The new device, which was given 510(k) clearance from the US Food and Drug Administration, allows for the remote diagnosis, monitoring, and assessment of epilepsy.
The new device, which was given...
01/06/2021
Neurology
News
AASM Publishes Guideline on Behavioral, Psychiatric Treatments for Insomnia
12/17/2020
The new guideline contains 1 strong recommendation and several conditional recommendations regarding the use of behavioral and psychiatric treatments among adults with chronic insomnia disorder.
The new guideline contains 1 strong recommendation and several conditional recommendations regarding the use of behavioral and psychiatric treatments among adults with chronic insomnia disorder.
The new guideline contains 1...
12/17/2020
Neurology
News
FDA Warns Against Use of Face Masks With Metal During MRI
12/08/2020
The US Food and Drug Administration has issued a safety communication regarding the types of face masks worn during a magnetic resonance imaging exam.
The US Food and Drug Administration has issued a safety communication regarding the types of face masks worn during a magnetic resonance imaging exam.
The US Food and Drug...
12/08/2020
Neurology

Advertisement

News
SUDEP Significantly More Common Among Infants, Children Than Previously Thought
12/04/2020
In a new study presented at the American Epilepsy Society virtual meeting, AES2020, researchers identified specific age groups that were most at risk for sudden unexpected death in epilepsy in a registry of patients aged 0 to 17 years.
In a new study presented at the American Epilepsy Society virtual meeting, AES2020, researchers identified specific age groups that were most at risk for sudden unexpected death in epilepsy in a registry of patients aged 0 to 17 years.
In a new study presented at the...
12/04/2020
Neurology
News
More than 1 in 10 Youth With Epilepsy Have Unrecognized Suicidality, Study Suggests
12/04/2020
Researchers investigated the prevalence of undiagnosed depression and anxiety, as well as unrecognized suicidality, among children and youth with epilepsy without an established psychiatric diagnosis. The findings were presented at the...
Researchers investigated the prevalence of undiagnosed depression and anxiety, as well as unrecognized suicidality, among children and youth with epilepsy without an established psychiatric diagnosis. The findings were presented at the...
Researchers investigated the...
12/04/2020
Neurology
News
Study Confirms Strong Association Between PNES and Sexual Assault Trauma Among Women
12/04/2020
New findings presented at the American Epilepsy Society virtual meeting, AES2020, indicate that people with psychogenic nonepileptic seizures, especially women, are significantly more likely to have experienced sexual assault trauma.
New findings presented at the American Epilepsy Society virtual meeting, AES2020, indicate that people with psychogenic nonepileptic seizures, especially women, are significantly more likely to have experienced sexual assault trauma.
New findings presented at the...
12/04/2020
Neurology

Advertisement

News
Alzheimer Disease: Adverse Financial Events Emerge Years Before Diagnosis
12/01/2020
In a new study, researchers investigated the prevalence of adverse financial events among Medicare beneficiaries with Alzheimer disease and related dementias (ADRD) in the years before and after diagnosis compared with demographically similar...
In a new study, researchers investigated the prevalence of adverse financial events among Medicare beneficiaries with Alzheimer disease and related dementias (ADRD) in the years before and after diagnosis compared with demographically similar...
In a new study, researchers...
12/01/2020
Neurology

Advertisement

Advertisement

News

Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
News
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
11/01/2024
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug...
11/01/2024
Neurology
Gene therapy
News
Concerns Linger After Gene Therapy Shows Long-Term Benefit for Cerebral Adrenoleukodystrophy
10/28/2024
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel...
10/28/2024
Neurology
Patient with family
News
During Recovery, Stroke Patients Benefit from Supportive Social Networks
10/24/2024
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and...
10/24/2024
Neurology
International Stroke Burden Saw Hike Over Last 30 Years
News
International Stroke Burden Saw Hike Over Last 30 Years
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has...
10/22/2024
Neurology
Hands holding a head in profile with an illustrated heart over brain
News
Antiseizure Meds May Increase Cardiovascular Risk in Older Adults With Epilepsy
10/21/2024
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy...
10/21/2024
Neurology
FDA approval stamp
News
FDA Approves Infusion Treatment for Advanced Parkinson Disease in Adults
10/18/2024
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa...
10/18/2024
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
News
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
10/15/2024
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to...
10/15/2024
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use